Clinical Trials Directory

Trials / Completed

CompletedNCT01571076

Preimplantation Genetic Screening (PGS) in Advanced Female Age and Male Severe Factor

Prospective and Randomized Study of the Use of Comparative Genomic Hybridization (CGH) Arrays to Study Embryo Aneuploidies in Female Advanced Age and Male Factor In Vitro Fertilization (IVF) Patients.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Igenomix · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Preimplantation Genetic Screening (PGS) is used for the selection of chromosomally normal embryos before the transfer in IVF treatments in many cases. There is great debate in the scientific community as to whether this is an efficient practice in patients of different prognosis. This prospective and randomized study seeks to study the results of chromosomal diagnosis using the new Comparative Genomic hybridization (CGH) arrays technique by practicing Preimplantation Genetic Screening (PGS) in day three biopsy on one arm of the study and not on the other arm in order to compare the results. The investigators will study the ongoing pregnancy rate of each oocyte retrieval and the ongoing implantation rate with Day 5 embryos (blastocysts) in IVF/ intracytoplasmic sperm injection (ICSI) treatments of embryos from two different groups of patients: Advanced Age Female Patients (38 - 41 years of age) and Male severe factor (≥2 million spermatozoids/ml.).

Detailed description

The randomized controlled trial results of advanced maternal age was completed and published (Rubio et al., Fertility\&Sterility 2017). The randomized controlled trial results of the male factor indication was terminated with anticipation due to the change of the technology that prevented recruitment of patients using the old technology (that one used in the study).

Conditions

Interventions

TypeNameDescription
GENETICPGSPreimplantation Genetic Screening of the embryos and posterior transfer of ongoing Day 5 blastocysts.
GENETICPGSPreimplantation Genetic Screening of the embryos and posterior transfer of ongoing Day 5 blastocysts.
OTHERProlonged cultureThe embryos will be in prolonged culture and on going embryos transferred on Day 5 .
OTHERProlonged cultureProlonged culture of the embryos and posterior transfer of ongoing Day 5 blastocysts.

Timeline

Start date
2012-02-01
Primary completion
2014-09-01
Completion
2015-02-01
First posted
2012-04-04
Last updated
2021-01-19

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01571076. Inclusion in this directory is not an endorsement.